Reversing AMD?
In a small clinical trial published in Ophthalmology, a prosthetic retinal device has proved its ability to restore eyesight to people who are blinded by age-related macular degeneration (AMD).
Staff reporters1 min read
Advertisement
In a small clinical trial published in Ophthalmology, a prosthetic retinal device has proved its ability to restore eyesight to people who are blinded by age-related macular degeneration (AMD).
Increasing the number of Māori entering eye health professions is the aim of a collaboration between the University of Auckland School of Vision Science (SOVS), Toku Eyes and the Te Whe pilot programme for Year 10 rangatahi (young people).
Recommendations to standardise definitions for age-related macular degeneration (AMD) and its subtypes have been made by an international working group of retina specialists, ocular pathologists and imaging experts.
Forging a new pathway to help Kiwis to see more clearly, Eye Health Aotearoa launched in parliament late this summer.
Swedish researchers have developed a new, less invasive screening model for predicting retinopathy of prematurity (ROP) in infants.
The following is special Covid-19 update from the Optometrists and Dispensing Opticians Board (ODOB) regarding NZ triage guidelines FROM THE ODOB BOARD As you are aware optometrists may assist in
Researchers and the American Academy of Ophthalmology (AAO) are warning that conjunctivitis, or pink eye, is a possibly sign of Covid-19. A new Chinese study, published in Jama Ophthalmology, found
A colour-changing smart contact lens that indicates eye moisture and pressure changes could be used to diagnose common eye diseases, such as xerophthalmia and glaucoma.
Due to an expected surge in demand for Australian health workers in response to the Covid-19 pandemic, the Australian Health Practitioner Regulation Agency (AHPRA) has established a new pandemic
Blind Low Vision NZ is uniting with blind, low vision, deafblind and other organisations to ensure Kiwis living with sight loss have access to the essentials during the Covid-19 crisis.“Access to
INXS guitarist Kirk Pengilly was diagnosed with non-hereditary glaucoma at the age of 29.
New Zealand company Medix21, best known for being a leading provider of rehabilitation equipment in Australasia, is returning to its ophthalmological roots by launching Medix21 Surgical to offer a new range of ophthalmological surgical products to the market.